May 2018 Newsletter
Looking for a free year of lab space at San Francisco's premier life sciences incubator?  Amgen can help!
Amgen is awarding up to 2 Golden Tickets to high-potential and innovative life science and biotech startups that have the ability to impact patients' lives. A Golden Ticket offers:  
  • Priority admission/renewal for one year's use of MBC BioLabs lab bench and Fast-track core facility, providing everything your startup needs to be successful
  • Unique access to Amgen scientific and business leaders
Please apply for an Amgen Golden Ticket by May 18, 2018. To apply, submit your non-confidential company presentation online. Amgen will award Golden Ticket winners in June 2018!
GraphWear Technologies Raises a $4.2M Series A
GraphWear makes a graphene-based sensor technology that can provide biological information from sweat. Initially ideated to provide performance athletes with advanced information, the latest use case in the works for GraphWear is aimed at a needle-free glucose test, expected to hit the market three to four years down the line after the necessary Food and Drug Administration clearances.  Full Press Release
Indee Labs Secures Funding to Develop Unique Gene Therapy Manufacturing Technology in Australia

Indee Labs will receive grant funding of nearly $1M from the Australian Government's $35 million BioMedTech Horizons program. The project will see Indee Labs make a new generation of medicine, known as gene therapy, accessible to the masses. The impact of gene therapies will be similar to that of antibiotics seen during the last century – it will offer cures for most cancer sufferers with minimal side effects. Kymriah and Yescarta were the first to be approved by the United States Food and Drug Administration last year and there are many hundreds more in development.  Full Press Release

Corning Sponsorship in San Carlos
Corning is pleased to announce sponsorship of the new MBC BioLabs site at San Carlos with the placement of several brand new instruments! Corning is a trusted supplier to the healthcare and pharmaceutical industries since we introduced PYREX® glass in 1915. Today, We are a leader in lab products, cell culture solutions, bioprocess vessels, and specialty surfaces. Corning Life Sciences provides high quality, innovative products for Life Science applications enabling people around the world to make and deliver life changing discoveries. We have trusted brands (Corning, Pyrex, Falcon, Axygen), backed by technical expertise.
Congratulations to Indee Labs with their success and growth to their own space in Emeryville!Indee Labs was founded on the idea that everyone should be able to access safe, effective and affordable healthcare designed to deliver optimal patient outcomes. Indee is developing hardware for gene delivery. Our hardware is uniquely positioned for the efficient development and scalable manufacturing of gene-modified cell therapies. Please join us as we Celebrate Indee Labs on Friday, May 4, 2018, 3:30 PM at 953 Indiana Street, San Francisco. Star Wars gear and outfits welcome!
Lunch Seminar: May 15, 12:30 PM - 2:00 PM Reimaging Clinical Trials and Drug Development RSVP As a biotech company matures, clinical trials will take up a disproportionate amount of resources for a clinical stage company. The CEO of Trialspark, Benjamine Liu, will give an overview of some of the opportunities to reimagine the clinical trial and significantly reduce the time and cost of development.
Benjamin Liu, DPhil CEO, Trialspark
Benjamine Liu is the co-founder and CEO of Trialspark, a technology company that runs end to-end clinical trials for biopharma. Benjamine received his DPhil from Oxford, conducting his graduate work with Sir Simon Lovestone. His doctoral thesis leveraged machine-learning and 'omics' to identify diagnostic tests and therapeutic targets for Parkinson's and Alzheimer's disease. During his graduate work, he was exposed to how clinical trials bottlenecked the development of new drugs, compelling him to start Trialspark.
Lunch Seminar: May 16, 12:00 PM - 2:00 PM Australia for Early Phase Clinical Development RSVP
Novotech and CoSec will be onsite to discuss the advantageous Australian regulatory landscape for early phase clinical development. Fast regulatory timelines and the 43.5% research and development Tax Rebate make Australia an ideal destination for small biotech companies entering clinical trials. 
Alex Ireland, MPH Business Development Associate Alex Ireland has been working in the biotech industry for the past five years from sales to operations, and has been working for Novotech for the past year. She is passionate about working with small-biotech companies and educating them on the benefits of running clinical trials in the Asia Pacific. Born and raised in the Bay Area, she earned a Master's Degree from Boston Pharmaceuticals in Epidemiology and International Health.